Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind his company’s success.   Benjamin, as an industry veteran within the Hong Kong medical devices sector, with also a factory presence in Dapeng district in Shenzhen, could you first share your perspective on what this Greater Bay Area initiative might mean for Hong Kong medtech companies? I must start with the caveat that the Greater Bay Area or GBA is a huge region with nine cities and three different administrative systems. Hong Kong companies – including mine – may not necessarily be familiar with all aspects of the entire region. We certainly have a better understanding of the cities closest to us like Shenzhen, and less so as you head west to Jiangmen and Zhaoqing. The initiative is certainly attractive insofar as there are still many unknowns, because unknowns represent opportunities for companies. On the retail and marketing side, the market size is attractive and very reachable; Hong Kong’s language, geographical and cultural proximity to the GBA population definitely brings us closer. For medtech companies, there should be easier access to the market, and efficient time and communication management.

On the retail and marketing side, the GBA market size is attractive and very reachable; Hong Kong’s language, geographical and cultural proximity to the GBA population definitely brings us closer